STAT5b deficiency: Lessons from STAT5b gene mutations

Levy, 2002, STATs: transcriptional control and biological impact, Nature Reviews Molecular Cell Biology, 3, 651, 10.1038/nrm909

Stahl, 1995, Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors, Science, 267, 1349, 10.1126/science.7871433

Kaneko, 2010, Loops govern SH2 domain specificity by controlling access to binding pockets, Science Signalling, 3, ra34, 10.1126/scisignal.2000796

Dupuis, 2001, Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation, Science, 293, 300, 10.1126/science.1061154

Dupuis, 2003, Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency, Nature Genetics, 33, 388, 10.1038/ng1097

Chapgier, 2006, Human complete STAT-1 deficiency is associated with defective type 1 and II IFN responses in vitro but immunity to some low virulence viruses in vivo, Journal of Immunology, 176, 5078, 10.4049/jimmunol.176.8.5078

Minegishi, 2007, Dominant-negative mutations in the DNA-binding domains of STAT3 cause hyper-IgE syndrome, Nature, 448, 1058, 10.1038/nature06096

Renner, 2007, STAT3 mutation in the original patient with Job's syndrome, New England Journal of Medicine, 357, 1667, 10.1056/NEJMc076367

Kofoed, 2003, Growth-hormone insensitivity (GHI) associated with a STAT-5b mutation, New England Journal of Medicine, 349, 1139, 10.1056/NEJMoa022926

Leonard, 1998, JAKS and STATS: biological implications, Annual Review of Immunology, 16, 293, 10.1146/annurev.immunol.16.1.293

Hennighausen, 2008, Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B, Genes & Development, 22, 711, 10.1101/gad.1643908

Ambrosio, 2002, The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter, Gene, 285, 311, 10.1016/S0378-1119(02)00421-3

Beausoleil, 2006, A probability-based approach for high-throughput protein phosphorylation analysis and site localization, Nature Biotechnology, 24, 1285, 10.1038/nbt1240

Daub, 2008, Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle, Molecular Cell, 31, 438, 10.1016/j.molcel.2008.07.007

Mayya, 2009, Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions, Science Signalling, 2, RA46, 10.1126/scisignal.2000007

Choudhary, 2009, Lysine acetylation targets protein complexes and co-regulates major cellular functions, Science, 325, 834, 10.1126/science.1175371

Baker, 1993, Role of insulin-like growth factors in embryonic and postnatal growth, Cell, 75, 73, 10.1016/0092-8674(93)90680-O

Liu, 1993, Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-I) and type I IGF receptor (Igflr), Cell, 75, 59

Laron, 1993, Laron syndrome due to a post-receptor defect: response to IGF-I treatment, Israel Journal of Medical Sciences, 29, 757

Lopez-Bermejo, 2000, Genetic defects of the growth hormone-insulin-like growth factor axis, Trends in Endocrinology & Metabolism, 11, 39, 10.1016/S1043-2760(99)00226-X

Dattani, 2004, Growth hormone deficiency and related disorders: insights into causation, diagnosis and treatment, Lancet, 363, 1977, 10.1016/S0140-6736(04)16413-1

Savage, 2005, IGFs and IGFBPs in GH insensitivity, Endocrine Development, 9, 100, 10.1159/000085760

Rosenfeld, 2006, Molecular mechanisms of IGF-I deficiency, Hormone Research, 65, 15, 10.1159/000090642

Woods, 1996, Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene, New England Journal of Medicine, 335, 1363, 10.1056/NEJM199610313351805

Walenkamp, 2005, Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation, Journal of Clinical Endocrinology & Metabolism, 90, 2855, 10.1210/jc.2004-1254

Netchine, 2009, Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF-1 mutation demonstrates its critical role in growth and brain development, Journal of Clinical Endocrinology & Metabolism, 94, 3913, 10.1210/jc.2009-0452

Laron, 1999, Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome), Journal of Pediatric Endocrinology & Metabolism, 1, 231

Rosenbloom, 2000, Physiology and disorders of the growth hormone receptor (GHR) and GH–GHR signal transduction, Endocrine, 12, 107, 10.1385/ENDO:12:2:107

Rosenfeld, 1994, Growth hormone (GH) insensitivity due to primary GH receptor deficiency, Endocrine Reviews, 15, 369, 10.1210/edrv-15-3-369

Brown, 2005, Model for growth hormone receptor activation based on subunit rotation within a receptor dimer, Nature Structural & Molecular Biology, 12, 814, 10.1038/nsmb977

Derr MA, Fang P, Sinha SK, et-al. A novel Y332C missense mutation in the intracellular domain of the human growth hormone receptor (GHR) does not alter STAT5b signaling: redundancy of GHR intracellular tyrosines involved in STAT5b signaling. Hormone Research in Paediatrics in press.

Savage, 2006, Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders, Nature Clinical Practice Endocrinology & Metabolism, 2, 395, 10.1038/ncpendmet0195

Chia, 2010, Dispersed chromosomal STAT5B-binding elements mediate growth hormone-activated insulin-like growth factor-I gene transcription, Journal of Biological Chemistry, 285, 17636, 10.1074/jbc.M110.117697

Wang, 2005, Identification of a distal STAT-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression, Journal of Biological Chemistry, 280, 10955, 10.1074/jbc.M412808200

Milward, 2004, Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT5 signal transduction, Journal of Clinical Endocrinology & Metabolism, 89, 1259, 10.1210/jc.2003-031418

Holland, 2007, STAT3 mutations in the hyper-IgE syndrome, New England Journal of Medicine, 357, 1608, 10.1056/NEJMoa073687

Woellner, 2010, Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome, Journal of Allergy and Clinical Immunology, 125, 424, 10.1016/j.jaci.2009.10.059

Udy, 1997, Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression, Proceedings of the National Academy of Sciences of the United States of America, 94, 7239, 10.1073/pnas.94.14.7239

Teglund, 1998, STAT5A and STAT5B proteins have essential and nonessential, or redundant, roles in cytokine responses, Cell, 93, 841, 10.1016/S0092-8674(00)81444-0

Zhou, 1997, A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse), Proceedings of the National Academy of Sciences of the United States of America, 94, 13215, 10.1073/pnas.94.24.13215

Rosenfeld, 2007, Defects in growth hormone receptor signaling, Trends in Endocrinology & Metabolism, 18, 134, 10.1016/j.tem.2007.03.004

Rosenfeld, 2009, The growth hormone cascade and its role in mammalian growth, Hormone Research, 71, 36, 10.1159/000192434

Chen, 1998, Crystal Structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA, Cell, 93, 827, 10.1016/S0092-8674(00)81443-9

Chia, 2006, Aberrant folding of a mutant STAT5b causes growth hormone insensitivity and proteasomal dysfunction, Journal of Biological Chemistry, 281, 6552, 10.1074/jbc.M510903200

Fang, 2006, A mutant signal transducer and activator of transcription 5B, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor, Journal of Clinical Endocrinology & Metabolism, 91, 1526, 10.1210/jc.2005-2558

Martinez, 2007, Novel STAT5b gene mutation in a patient presenting GH insensitivity and innumodeficiency, Hormone Research, 68, 33

Lappalainen, 2008, Genome wide analysis of pathogenic SH2 domain mutations, Proteins, 72, 779, 10.1002/prot.21970

Pugliese-Pires, 2010, A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings, European Journal of Endocrinology, 163, 349, 10.1530/EJE-10-0272

Bernasconi, 2006, Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation, Pediatrics, 118, e1584, 10.1542/peds.2005-2882

Boyanovsky, 2009, Growth hormone insensitivity and immunodeficiency: mutation in the STAT5B gene

Hwa, 2005, Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b, Journal of Clinical Endocrinology & Metabolism, 90, 4260, 10.1210/jc.2005-0515

Vidarsdottir, 2006, Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation, Journal of Clinical Endocrinology & Metabolism, 91, 3482, 10.1210/jc.2006-0368

Hwa, 2007, Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon13–intron13 junction of the STAT5b gene, Hormone Research, 68, 218, 10.1159/000101334

Laron, 1993, Growth curves for Laron syndrome, Archives of Disease in Childhood, 68, 768, 10.1136/adc.68.6.768

Walenkamp, 2007, Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation, European Journal of Endocrinology, 156, 155, 10.1530/eje.1.02327

Rubinstein, 1988, Corticosteroid treatment for pulmonary lymphoid hyperplasia in children with the acquired immune deficiency syndrome, Pediatric Pulmonology, 4, 13, 10.1002/ppul.1950040105

Cohen, 2006, Cutting Edge: decreased accumulation and regulatory function of CD4+CD25high T cells in human STAT5b deficiency, Journal of Immunology, 177, 2770, 10.4049/jimmunol.177.5.2770

Burchill, 2007, Interleukin-2 receptor signaling in regulatory T cell development and homeostasis, Immunology Letters, 114, 1, 10.1016/j.imlet.2007.08.005

Torgerson, 2008, Immune dysregulation in primary immunodeficiency disorders, Immunology and Allergy Clinics of North America, 28, 315, 10.1016/j.iac.2008.02.002

Zorn, 2006, IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo, Blood, 108, 1571, 10.1182/blood-2006-02-004747

Yao, 2007, Nonredundant roles for STAT5a/b in directly regulating Foxp3, Blood, 109, 4368, 10.1182/blood-2006-11-055756

Riley, 2009, Human T regulatory cell therapy: take a billion or so and call me in the morning, Immunity, 30, 656, 10.1016/j.immuni.2009.04.006

Bright, 2009, Recombinant human insulin-like growth factor-1 treatment: ready for primetime, Endocrinology Metabolism Clinics of North America, 38, 625, 10.1016/j.ecl.2009.06.003

den Dunnen, 2001, Nomenclature for the description of human sequence variations, Human Genetics, 109, 121, 10.1007/s004390100505